ASTH Earnings

ASTH reported its earnings on 2026-03-02, showcasing a revenue of 950.53M against an estimate of 923.83M, resulting in a 2.89% surprise. The EPS was 0.54, surpassing the expected 0.15 by 260%. The stock experienced a 29.46% price change on the earnings day and a 23.32% change over the next five days, reflecting market reactions to the results.

Following ASTH's earnings announcement on 2026-03-02, the stock price moved by 29.46% on the day of the release. Over the subsequent five days, it saw a 23.32% change. Historically, ASTH's stock price tends to shift by an average of -0.92% in the 10 days leading up to earnings and -4.5% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ASTH's annual revenue to reach 919.85M, while the EPS is projected at 0.24. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised downward by -0.08% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ASTH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised downward by -0.08%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ASTH's stock price typically moves by -0.92% in the 10 days before its earnings and -4.5% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.24 and revenue of 919.85M.

The earnings call indicates strong financial performance with record-high adjusted EPS and optimistic guidance for 2026 and 2027. The integration of Prospect Health and strategic partnerships are progressing well, and AI tools are enhancing operational efficiency. Despite some concerns about Medicaid disenrollments and management's lack of specific quantifications, the overall sentiment is positive. The expanded partnerships and AI deployment are likely to boost short-term stock price, leading to a positive outlook.